The move is in response to the challenges brought by the rapid growth of COVID-19 cases in some countries to China's efforts to prevent imported cases, said Mi Feng, a spokesperson for the National Health Commission at a press conference.
The capabilities in nucleic acid testing, epidemiological investigations, concentrated isolation and medical treatment at ports of entry will be enhanced, to guard against imported cases, he said.
Latest comments